Using urine samples to detect bladder cancer cells non-invasively
Validating Urine Derived Cancer Cells (UDCC) -- Non-Invasive and Living Liquid Biopsies -- in Bladder Cancer Clinics
This study is looking at a new, gentle way to find bladder cancer by testing urine samples for cancer cells, which could help patients avoid more invasive tests and lead to better treatment options.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-10605346 on NIH RePORTER |
What this research studies
This research focuses on developing a non-invasive method to detect bladder cancer by analyzing urine-derived cancer cells. By utilizing liquid biopsies, the study aims to improve the accuracy of bladder cancer diagnosis and monitoring, potentially reducing the need for invasive procedures like cystoscopy. The approach involves collecting urine samples from patients and analyzing them for cancer cells, which could lead to better treatment decisions and outcomes. The goal is to create a more cost-effective and efficient way to manage bladder cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with bladder cancer, particularly those at non-muscle-invasive stages.
Not a fit: Patients with advanced bladder cancer who are already undergoing aggressive treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate detection of bladder cancer, improving patient outcomes and reducing healthcare costs.
How similar studies have performed: Other studies have shown promise in using liquid biopsies for cancer detection, indicating that this approach could be a viable option for bladder cancer as well.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Liu, Xuefeng — Ohio State University
- Study coordinator: Liu, Xuefeng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.